Ofori-Asenso R, Pollock AM, Brhlikova P. Poor prescription practices across Africa are putting patients at risk. The Conversation 29 Aug 2016.
Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16:724. download
Leng HJ, Sanders D. Who is to blame for the medicines backlog? 2015
McGettigan P. India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated. The Conversation 20 July 2015.
Leng HJ, Mutoti KP, Mbelle N. Regulatory requirements for the development and registration of biosimilars in South Africa. GaBI Journal. 2015
Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal. Globalization and Health. 2015;11(25). download
McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock, AM. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs. PLoS Med. 2015;12(5):e1001826. download
Millard C, Brhlikova P, Pollock AM. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list. Social Science & Medicine. 2015;132:190–6. download
Maigetter K, Pollock AM, Kadam A, Ward K, Weiss MG. Pharmacovigilance in India, Uganda and South Africa with reference to WHO’s minimum requirements. Int J Health Policy Manag. 2015;4;5:295-305. download dissemination video
Leng HJ, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. GaBi Journal. 2015;4(2).
Atukunda, EC, Brhlikova P, Agaba AG, Pollock AM. Civil Society Organizations and medicines policy change: A case study of registration, procurement, distribution and use of misoprostol in Uganda. Social Science & Medicine. 2015;130:242–9. download
Evans V, Pollock AM. The proliferation of irrational metformin fixed-dose combinations in India. The Lancet Diabetes and Endocrinology. 2015;3(2):98–100. download
Magadzire BP, Budden A, Ward K, Jeffery R, Sanders D. Frontline health workers as brokers: provider perceptions, experiences and mitigating strategies to improve access to essential medicines in South Africa. BMC Health Services Research. 2014;14:520.
Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, et al. The availability of six tracer medicines in private medicine outlets in Uganda. Journal of Pharmaceutical Policy and Practice. 2014;7(18). download
Ward K, Sanders D, Leng H, Pollock AM. Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme. Bulletin of the WHO. 2014;92:482–9. download
Millard C, Pollock AM, Brhlikova P. Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health. BMJ. 2014;349:g4823. download
McGettigan P, Pollock AM, Herxheimer A. MPs call for full results of all past clinical trials to be made public. BMJ. 2014 Jan 3;348(jan03 1):g13–g13.
Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet. 2013;382(Supplement 1):10. download
Chinai R, Kadam A, Pollock AM, Jeffery R, Weiss MG, Mistry N. Access to medicines under India’s National Disease Control Programmes: local study of TB, HIV and malaria medicines. AMASA; 2013.
Chinai R, Kadam A, Mahajan R, Pollock AM, Jeffery R, Maigetter K, et al. Inadequately enforced workforce planning norms undermine safety of Indian drugs. AMASA; 2013.
Chinai R, Kadam A, Mahajan R, McGettigan P, Pollock AM, Jeffery R, et al. ‘Fixed Dose Combination’ drugs and the case of Metformin. AMASA; 2013.
Chu CS, Brhlikova P, Pollock AM. Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage. JRSM 2012;105:336–47.
Mattheij I, Pollock A, Brhlikova P. Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness. JRSM 2012;105:250–62. download
Pollock A, Brhlikova P, McGettigan P. Reviewer’s commentary on ‘Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence’. BJOG : an international journal of obstetrics and gynaecology 2012;:11. download
Richardson E, Pollock A. Community pharmacy: moving from dispensing to diagnosis and treatment. BMJ 2010;340:c2298. download
Pollock AM, Price D. Briefing on the specification of pharmaceutical product defects. Centre for International Public Health Policy 2009. download
Kerrison S, Pollock AM. The reform of UK research ethics committees: throwing the baby out with the bath water? Journal of Medical Ethics 2005;31:487–9. download
Kerrison S, McNally N, Pollock AM. United Kingdom research governance strategy: Authors’ reply. BMJ 2004;328:50–50. download
McNally N, Kerrison S, Pollock A. Reforming clinical research and development in England. BMJ 2003;327:550–3. download